Development of a simplified protocol for administration of 20% magnesium sulphate for prophylaxis and treatment of eclampsia

Canadian Journal of Hospital Pharmacy

Volumn 62, Issue 6, 2009, Pages 490-495

  Palmer, Lynne ^a   Newby, Brandi D ^a  

^a SURREY MEMORIAL HOSPITAL   (Canada)

Author keywords

Eclampsia; Magnesium sulphate; Patient safety; Pre eclampsia

Indexed keywords

MAGNESIUM SULFATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ECLAMPSIA; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MEDICATION ERROR; PHLEBITIS; PROPHYLAXIS;

EID: 75149194427     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: 10.4212/cjhp.v62i6.847     Document Type: Article

References (12)

1. BCRCP obstetric guideline 11: hypertension in pregnancy. Vancouver (BC): British Columbia Reproductive Care Program; 2006 [cited 2008 Jul 10]. Available from: http://www.bcphp.ca//sites/bcrcp/files/Guidelines/Obstetrics/ Hypertensionjune2006.pdf
2. Diagnosis, evaluation, and management of the hypertensive disorders in pregnancy [guideline 206]. J Obstet Gynaecol Can 2008 [cited 2008 Sep 27];30(3 Suppl 1):S1-S48. Available from: http://www.sogc.org/guidelines/index- e.asp#Obstetrics
3. Trissel LA. Handbook on injectable drugs. Bethesda (MD): American Society of Health-System Pharmacists; 2009.
4. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington (DC): Institute of Medicine and National Academy Press; 2000.
5. Simpson KR, Knox GE. Obstetrical accidents involving intravenous magnesium sulfate: recommendations to promote patient safety. MCN Am J Matern Child Nurs 2004;29(3):161-171.
6. Failure mode and effect analysis: Managing Obstetrical Risk Efficiendy (MOREOB) program. London (ON): Salus Global Corporation; 2008 [cited 2008 Jul 14]. Available from: https://secure.moreob.com/servlets/sfs?t=/contentManager/ onStory&e=UTF-8&i=1204141627843&l=0&active=no&sort= Price&StoryID=1206464922334. Registration required to access content.
7. Segatore M, Stromberg TV, Lokken L. Midclavicular carheters in the antepartum population. A continuous quality improvement review. J Intraven Nurs 1998;21(5):291-300.
8. Magnesium sulphate (MgSO4) infusion protocol for eclamptic seizure prophylaxis. North Sydney (Australia): New South Wales Department of Health; 2005 [cited 2008 Jul 10]. Available from: http://www.health.nsw.gov.au/policies/ PD/2005/PD2005-239.html
9. Magnesium sulphate: magnesium sulphate is the anticonvulsant of choice for pre-edampsia prophylaxis and treatment. Victoria (Australia): The Royal Women's Hospital; 2006 [cited 2008 Sep 27]. Available from: http://www. thewomens.org.au/MagnesiumSulphate
10. Bates DW, Vanderveen T, Seger DL, Yamaga C, Rothschild J. Variability in intravenous medication practices: implications for medication safety. Jt Comm J Qual Patient Saf 2005;31(4):203-210.
11. Dennison RD. High-alert drugs: strategies for safe I.V. infusions. Am Nurse Today 2006; 1(2). Available from: http://www.americannursetoday.com/ Article.aspx?id=5134&fid=5120
12. Newby BD, Benes C, Palmer L, Cleve R. Stability of magnesium sulfate 20% in Viaflex bags [letter]. Can J Hosp Pharm 2008;61(5):356-357.